Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)

Total article views   HTML views PDF downloads Totals
10,287 Dovepress* 8,871+ 2,118 10,989
PubMed Central* 1,416 1,319 2,735
Totals 10,287 3,437 13,724
*Since 25 July 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
5 0 0 0 1 4

View citations on PubMed Central and Google Scholar